Shares of Global X Interest Rate Hedge ETF (NYSEARCA:RATE – Get Rating) fell 0.3% during mid-day trading on Tuesday . The stock traded as low as $26.52 and last traded at $26.52. 1,251 shares changed hands during mid-day trading, an increase of 142% from the average session volume of 517 shares. The stock had previously closed at $26.60.
Global X Interest Rate Hedge ETF Price Performance
The firm's fifty day simple moving average is $25.32.
See Also
- Get a free copy of the StockNews.com research report on Global X Interest Rate Hedge ETF (RATE)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets "Powelled": S&P 500 Confirms Resistance
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Rivian Plummets, But Is This 2023's Greatest Buying Opportunity?
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for Global X Interest Rate Hedge ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Interest Rate Hedge ETF and related companies with MarketBeat.com's FREE daily email newsletter.
週二午盤，Global X利率對沖ETF(NYSEARCA：Rate-Get Rating)的股價下跌0.3%。該股一度跌至26.52美元，最後報26.52美元。午盤交易中有1,251股易手，較517股的平均日成交量增加142%。該股此前收盤價為26.60美元。
Global X利率對沖ETF價格表現
該公司的50日簡單移動均線為25.32美元。
另請參閱
- 免費獲取StockNews.com關於Global X利率對沖ETF(利率)的研究報告
- 低調的Azul SA公司乘著強勁的旅行需求起飛
- 市場受挫：標普500指數確認阻力
- Ulta內部人士持股：賣出-買入
- Rivian應運而生，但這是2023年最大的收購機會嗎？
- 潛在收益將Ambrx Biophma評為中等買入
接受Global X利率對沖ETF日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收關於Global X利率對沖ETF和相關公司的最新新聞和分析師評級的每日摘要。
